ArticleThe Journal of clinical investigation2025

GSK3B directs DNA repair choice and determines tumor response to PARP1 inhibition independent of BRCA1.

Heba S Allam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.